Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Quest Diagnostics Inc (DGX)

Quest Diagnostics Inc (DGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 17,232,592
  • Shares Outstanding, K 111,092
  • Annual Sales, $ 9,252 M
  • Annual Income, $ 854,000 K
  • 60-Month Beta 0.89
  • Price/Sales 1.87
  • Price/Cash Flow 12.19
  • Price/Book 2.60
Trade DGX with:

Options Overview Details

View History
  • Implied Volatility 18.94% ( -0.82%)
  • Historical Volatility 11.18%
  • IV Percentile 32%
  • IV Rank 27.70%
  • IV High 28.33% on 08/05/24
  • IV Low 15.34% on 11/22/23
  • Put/Call Vol Ratio 3.35
  • Today's Volume 448
  • Volume Avg (30-Day) 213
  • Put/Call OI Ratio 1.16
  • Today's Open Interest 9,710
  • Open Int (30-Day) 8,518

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 2.27
  • Number of Estimates 9
  • High Estimate 2.32
  • Low Estimate 2.23
  • Prior Year 2.22
  • Growth Rate Est. (year over year) +2.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
149.52 +2.38%
on 09/11/24
159.36 -3.94%
on 09/04/24
+2.17 (+1.44%)
since 08/20/24
3-Month
135.47 +13.00%
on 06/28/24
159.36 -3.94%
on 09/04/24
+14.88 (+10.77%)
since 06/20/24
52-Week
119.59 +28.00%
on 10/02/23
159.36 -3.94%
on 09/04/24
+28.07 (+22.45%)
since 09/20/23

Most Recent Stories

More News
Factors Driving Veeva Stock More Than 20% in Three Months

Shares of Veeva Systems VEEV have risen 20.5% in the past three months, outperforming both the industry as well as the S&P 500 Index. The outperformance was primarily driven by its strong quarterly results...

BSX : 83.69 (-0.02%)
DGX : 152.63 (-1.61%)
DVA : 163.11 (-0.02%)
VEEV : 213.01 (-0.64%)
SYK Stocks Gains Following Expansion of Foot & Ankle Portfolio

Stryker SYK recently announced the expansion of its Foot & Ankle portfolio with the introduction of two cutting-edge products — the Osteotomy Truss System (“OTS”) and the Ankle Truss System (“ATS”)....

BSX : 83.69 (-0.02%)
DGX : 152.63 (-1.61%)
SYK : 363.98 (-0.29%)
DVA : 163.11 (-0.02%)
VEEV Stock Up Following the Release of New Features of Veeva Site Connect

Veeva Systems Inc. VEEV recently announced the newest release of Veeva Site Connect. The release adds powerful new capabilities and a streamlined site-centric experience to simplify and standardize sponsor-site...

BSX : 83.69 (-0.02%)
DGX : 152.63 (-1.61%)
DVA : 163.11 (-0.02%)
VEEV : 213.01 (-0.64%)
COO Stock Up 0.4% Following the Launch of New Inserter for Paragard IUD

The Cooper Companies, Inc.’s COO business segment, CooperSurgical (CSI), announced the launch of a new inserter designed for single-hand placement of Paragard on Tuesday, which was recently approved...

BSX : 83.69 (-0.02%)
DGX : 152.63 (-1.61%)
DVA : 163.11 (-0.02%)
COO : 109.70 (-1.26%)
BD Stock Falls After Acquisition of Edwards' Critical Care Group

Becton, Dickinson, and Company BDX, popularly known as BD, completed its acquisition of Edwards Lifesciences Corporation EW Critical Care product group, renaming it BD Advanced Patient Monitoring.BD had...

BDX : 233.48 (-0.49%)
DGX : 152.63 (-1.61%)
UHS : 237.60 (-0.08%)
EW : 66.52 (-1.10%)
Elevance Health Stock Has More to Offer: Should You Hold on Tight?

Elevance Health, Inc. ELV is well-poised to grow on the back of Carelon’s business strength and commercial member growth. The company keeps expanding its operating margins for both Health Benefits and...

DGX : 152.63 (-1.61%)
UHS : 237.60 (-0.08%)
THC : 164.64 (-1.53%)
ELV : 536.35 (-0.31%)
Centene Shifts an AcariaHealth Facility to Shelby Township

Centene Corporation CNC recently announced that its specialty pharmacy subsidiary, AcariaHealth, has relocated its Homescripts pharmacy to a new 33,000-square-foot facility in Shelby Township, MI, to enhance...

DGX : 152.63 (-1.61%)
UHS : 237.60 (-0.08%)
THC : 164.64 (-1.53%)
CNC : 75.53 (-0.13%)
Catalent's Stock Gains on Q4 Earnings Beat, Gross Margin Up

Catalent, Inc. CTLT reported fourth-quarter fiscal 2024 adjusted earnings per share (EPS) of 65 cents, which was significantly up from the year-ago period’s EPS of 2 cents. The figure surpassed the Zacks...

BSX : 83.69 (-0.02%)
DGX : 152.63 (-1.61%)
DVA : 163.11 (-0.02%)
CTLT : 59.93 (-0.30%)
COO Stock Gains on Q3 Earnings & Revenue Beat, Margins Up

The Cooper Companies, Inc. COO delivered adjusted earnings per share (EPS) of 96 cents in the third quarter of fiscal 2024, which improved 14.3% year over year. The figure surpassed the Zacks Consensus...

BSX : 83.69 (-0.02%)
DGX : 152.63 (-1.61%)
DVA : 163.11 (-0.02%)
COO : 109.70 (-1.26%)
Quest Diagnostics Stock: Is Wall Street Bullish or Bearish?

As Quest Diagnostics underperformed relative to the S&P 500 Index over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.

DGX : 152.63 (-1.61%)
$SPX : 5,689.81 (-0.42%)
XHS : 97.20 (-0.73%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services...

See More

Key Turning Points

3rd Resistance Point 158.87
2nd Resistance Point 157.87
1st Resistance Point 156.50
Last Price 152.63
1st Support Level 154.13
2nd Support Level 153.13
3rd Support Level 151.76

See More

52-Week High 159.36
Last Price 152.63
Fibonacci 61.8% 144.17
Fibonacci 50% 139.48
Fibonacci 38.2% 134.78
52-Week Low 119.59

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar